Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Beat Estimates Zacks Equity Research - Zacks Investment Research - Wed Nov 6, 6:55AM CST Zacks Equity Research - ZACKS - Wed Nov 6, 6:55AM CST
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 15.38% and 1.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for...
Healthcare Stock Earnings Slated on Nov 6: HUM, ELAN & More Zacks Equity Research - Zacks Investment Research - Tue Nov 5, 9:40AM CST Zacks Equity Research - ZACKS - Tue Nov 5, 9:40AM CST
Rise in senior population, shift of care to lower-cost settings and decline in unemployment are likely to have driven healthcare sector earnings.
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q3 Earnings Expected to Decline Zacks Equity Research - Zacks Investment Research - Wed Oct 30, 9:34AM CDT Zacks Equity Research - ZACKS - Wed Oct 30, 9:34AM CDT
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis Appoints Kristin Peck as New CEO, Alaix to Retire Zacks Equity Research - Zacks Investment Research - Mon Oct 7, 8:51AM CDT Zacks Equity Research - ZACKS - Mon Oct 7, 8:51AM CDT
Zoetis (ZTS) names executive vice president Kristin Peck as the new CEO, effective Jan 1, 2020.
Zoetis (ZTS) Receives EC Approval for Simparica Trio in Dogs Zacks Equity Research - Zacks Investment Research - Mon Sep 23, 11:36AM CDT Zacks Equity Research - ZACKS - Mon Sep 23, 11:36AM CDT
Zoetis' (ZTS) leading animal health portfolio gets a boost with the approval of Simparica Trio.
Elanco to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference BusinessWire - Thu Sep 5, 4:00PM CDT CMTX - Thu Sep 5, 4:00PM CDT
Elanco Animal Health, Inc. (NYSE: ELAN) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, Sept. 11, 2019, in New York. Jeff Simmons, Elanco president and chief...
Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco Zacks Equity Research - Zacks Investment Research - Wed Aug 21, 7:56AM CDT Zacks Equity Research - ZACKS - Wed Aug 21, 7:56AM CDT
Bayer (BAYRY) inks deal with Elanco to divest its animal health business for $7.6 billion.
Bayer Sells Animal Health Division to Elanco: Now What? Mitchell Moore - Zacks Investment Research - Tue Aug 20, 5:38PM CDT Mitchell Moore - ZACKS - Tue Aug 20, 5:38PM CDT
On Tuesday, Bayer (BAYRY) announced the sale of its animal-health division to American competitor Elanco (ELAN), for a net price of $7.6 billion. The deal is expected to close in mid-2020 after regulatory...
Home Depot and Moderna rise while Fabrinet and Sarepta fall Associated Press - Tue Aug 20, 3:43PM CDT AP - Tue Aug 20, 3:43PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
Elanco Finalizes Acquisition of Aratana Therapeutics BusinessWire - Thu Jul 18, 7:31AM CDT CMTX - Thu Jul 18, 7:31AM CDT
Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics...
Elanco Appoints Art A. Garcia to Board of Directors BusinessWire - Wed May 8, 3:15PM CDT CMTX - Wed May 8, 3:15PM CDT
Elanco Animal Health (NYSE: ELAN) today announced the appointment of Art
A. Garcia, recently retired executive vice president and chief financial
officer of Ryder System Inc., to the Board...
ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX BusinessWire - Fri May 3, 4:39PM CDT CMTX - Fri May 3, 4:39PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the
law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the
proposed sale of Aratana Therapeutics (NasdaqGM: PETX)...
Lilly (LLY) Down Despite Q1 Earnings Beat on Sales View Cut Zacks Equity Research - Zacks Investment Research - Tue Apr 30, 10:31AM CDT Zacks Equity Research - ZACKS - Tue Apr 30, 10:31AM CDT
Eli Lilly's (LLY) earnings beat estimates in Q1. Stock falls in pre-market trading as the company lowers its full-year revenue forecast.
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aratana Therapeutics, Inc. (PETX) on Behalf of Stockholders and Encourages PETX Investors to Contact the Firm GlobeNewswire - Mon Apr 29, 4:28PM CDT CMTX - Mon Apr 29, 4:28PM CDT
Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Aratana Therapeutics, Inc. (NASDAQ: PETX) on behalf of stockholders concerning the proposed merger with Elanco...
QTNA, PETX, and SFS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers GlobeNewswire - Mon Apr 29, 12:00PM CDT CMTX - Mon Apr 29, 12:00PM CDT
Rigrodsky & Long, P.A. announces that it is investigating:
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc. PR Newswire - Fri Apr 26, 1:25PM CDT CMTX - Fri Apr 26, 1:25PM CDT
Rowley Law PLLC is investigating potential claims against Aratana Therapeutics, Inc. (NASDAQ: PETX) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company...
Aratana Therapeutics to be Acquired by Elanco Animal Health PR Newswire - Fri Apr 26, 5:28AM CDT CMTX - Fri Apr 26, 5:28AM CDT
Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, announced it has signed an agreement to be acquired...
Investor Expectations to Drive Momentum within Dermira, Elanco Animal Health, Ready Capital, Cushman & Wakefield, BlueLinx, and Lydall -- Discovering Underlying Factors of Influence GlobeNewswire - Tue Apr 9, 7:49AM CDT CMTX - Tue Apr 9, 7:49AM CDT
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Dermira, Inc. (NASDAQ:DERM), Elanco...
MagnaChip and ELAN Microelectronics Announce Partnership to Expand OLED Display Capabilities for Next-Generation Applications PR Newswire - Tue Apr 9, 7:05AM CDT CMTX - Tue Apr 9, 7:05AM CDT
MagnaChip Semiconductor Corporation ("MagnaChip" or the "Company") (NYSE: MX), a designer and manufacturer of analog and mixed-signal semiconductor products, and ELAN Microelectronics Corp. (TWSE:ELAN),...
